Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Orange Book Patents
Across 1 drug with upcoming expirations
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 1
R&D Momentum
12/100
Pipeline Velocity
0/100
Trial Completion Rate
83/100
Pipeline Concentration
50/100
Pipeline Freshness
73/100
Strategic Signals
Activity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Regulatory
Diprolene — DIPROSONE
Application NDA017781 (NDA)
Diprolene — DIPROSONE
Application NDA017829 (NDA)
Diprolene — DIPROSONE
Application NDA017691 (NDA)
Diprolene — DIPROSONE
Application NDA017536 (NDA)
Diprolene — DIPROLENE
Application NDA018741 (NDA)
Diprolene — BETAMETHASONE DIPROPIONATE
Application NDA019141 (NDA)
Diprolene — ALPHATREX
Application NDA019143 (NDA)
Diprolene — BETAMETHASONE DIPROPIONATE
Application NDA019140 (NDA)
Diprolene — ALPHATREX
Application NDA019138 (NDA)
Diprolene — BETAMETHASONE DIPROPIONATE
Application NDA019137 (NDA)
Diprolene — BETAMETHASONE DIPROPIONATE
Application NDA019136 (NDA)
Diprolene — DIPROLENE
Application NDA019408 (NDA)
Diprolene — DIPROLENE AF
Application NDA019555 (NDA)
Diprolene — DIPROLENE
Application NDA019716 (NDA)
Diprolene — SERNIVO
Application NDA208079 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)